William J. Weiner
#125,272
Most Influential Person Now
William J. Weiner's AcademicInfluence.com Rankings
William J. Weinermedical Degrees
Medical
#1988
World Rank
#2377
Historical Rank
Neurology
#193
World Rank
#266
Historical Rank
Download Badge
Medical
Why Is William J. Weiner Influential?
(Suggest an Edit or Addition)William J. Weiner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Criteria for the diagnosis of corticobasal degeneration (2013) (1198)
- Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. (2000) (921)
- Parkinson’s Disease and Movement Disorders (2000) (672)
- Non-recognition of depression and other non-motor symptoms in Parkinson's disease. (2002) (624)
- Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. (2004) (609)
- Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology (2006) (496)
- Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: Summary statement (2002) (489)
- Comorbidity of the nonmotor symptoms of Parkinson's disease (2001) (407)
- The clinically important difference on the unified Parkinson's disease rating scale. (2010) (407)
- Sleep disorders and sleep effect in Parkinson's disease (1990) (366)
- Practice Parameter: Therapies for essential tremor (2005) (340)
- Nerve growth factor and Alzheimer's disease (1986) (339)
- Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. (2013) (330)
- Cognitive impairments associated with early Parkinson's disease (1989) (307)
- Visuospatial impairment in Parkinson's disease (1991) (294)
- Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain (1986) (288)
- Practice parameter: Initiation of treatment for Parkinson’s disease: An evidence-based review (2002) (280)
- Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease (2010) (271)
- Sleep Disruption in the Course of Chronic Levodopa Therapy: An Early Feature of the Levodopa Psychosis (1982) (251)
- The evolution of disability in Parkinson disease (2008) (243)
- Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology (2006) (232)
- A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease (2006) (224)
- Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) (2006) (217)
- A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease (2007) (204)
- Gait abnormality in essential tremor (2004) (193)
- Parkinson's Disease: Diagnosis and Clinical Management (2007) (191)
- Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. (1988) (175)
- Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology (2006) (163)
- Levodopa‐Induced dopamine receptor hypersensitivity (1977) (162)
- Evidence-based guideline update: Treatment of essential tremor (2011) (154)
- Quality improvement in neurology: AAN Parkinson disease quality measures (2010) (149)
- Chorea induced by oral contraceptives (1979) (147)
- Gilles de la Tourette syndrome after long‐term chlorpromazine therapy (1978) (145)
- Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease (1993) (132)
- Autonomic dysfunction in men with Parkinson's disease. (1992) (131)
- A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. (1992) (128)
- Acupuncture therapy for the symptoms of Parkinson's disease (2002) (122)
- Movement Disorders: A Comprehensive Survey (1989) (120)
- 5‐Hydroxytryptophan‐induced myoclonus in guinea pigs and the possible role of serotonin in infantile myoclonus (1973) (119)
- Evidence-based guideline: Treatment of tardive syndromes (2013) (118)
- Subjective report versus objective measurement of activities of daily living in Parkinson's disease (2006) (112)
- Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. (1978) (111)
- Impact of psychogenic movement disorders versus Parkinson's on disability, quality of life, and psychopathology (2007) (111)
- Side of onset of motor symptoms influences cognition in Parkinson's disease (1993) (108)
- From fruit fly to bedside: translating lessons from Drosophila models of neurodegenerative disease (2003) (104)
- Characterization and Distribution of Transferrin Receptors in the Rat Brain (1990) (102)
- Modification of postsynaptic dopaminergic sensitivity by female sex hormones. (1979) (102)
- Drug holiday and management of Parkinson disease (1980) (96)
- Can peripheral trauma induce dystonia? No! (2001) (91)
- Selective Destruction of Cultured Dopaminergic Neurons from Fetal Rat Mesencephalon by 1‐Methyl‐4‐Phenylpyridinium: Cytochemical and Morphological Evidence (1988) (88)
- Sydenham chorea (1980) (88)
- Mutuality of the marital relationship in Parkinson's disease (2008) (86)
- Side and type of motor symptom influence cognition in Parkinson's disease (2006) (84)
- Prior history of head trauma in Parkinson's disease (1991) (83)
- Treatment and prognosis of hemiballismus. (1976) (83)
- Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study) (2012) (82)
- Psychosis as the initial manifestation of adult-onset Niemann-Pick disease type C (1995) (81)
- 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons (1986) (80)
- Trauma as an etiology of parkinsonism: A historical review of the concept (1988) (78)
- Dystonic foot response of Parkinsonism. (1980) (75)
- The pharmacology of choreatic movement disorders (1976) (75)
- Hemiballismus: current concepts and review. (2012) (73)
- There is no Parkinson disease. (2008) (72)
- Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias1 (1974) (72)
- What determines resilience in patients with Parkinson's disease? (2012) (67)
- Racial and socioeconomic disparities in parkinsonism. (2011) (66)
- Behavioral Neurology of Movement Disorders (1995) (65)
- The effect of d‐amphetamine on choreiform movement disorders (1974) (65)
- The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease. (1995) (64)
- Large cerebral vessel disease in sickle cell anaemia. (1976) (64)
- Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior. (1972) (64)
- Dopamine binding following prolonged haloperidol pretreament (1978) (62)
- An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. (2002) (62)
- The effect of pregnancy in Parkinson's disease (2000) (60)
- Psychogenic dystonia and peripheral trauma (2011) (60)
- Practice Parameter: Evaluation and in Treatment of Depression, Psychosis and Dementia Parkinson Disease (An Evidence-Based Review) (2006) (59)
- Psychogenic tremors (1989) (58)
- The use of dopamine agonists in very elderly patients with Parkinson's disease (2000) (58)
- Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior. (1973) (57)
- Serotonergic and antiserotonergic influences on apomorphine-induced stereotyped behaviour. (2009) (56)
- Internal tremor in patients with Parkinson's disease (1996) (56)
- Electrical properties of motor units in Parkinsonism and a possible relationship with bradykinesia (1979) (55)
- The initial treatment of Parkinson's disease should begin with levodopa (1999) (55)
- Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. (2016) (54)
- L-dopa and cerebrospinal fluid homovanillic acid in Parkinsonism. (1969) (53)
- Coprolalia in younger patients with Gilles de la tourette syndrome (1994) (52)
- A comparative study of physical performance measures in Parkinson's disease (2008) (52)
- Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice (1991) (52)
- The effect of lithium on an animal model of tardive dyskinesia. (1977) (52)
- Dual task performance in Parkinson's disease: a sensitive predictor of impairment and disability. (2013) (51)
- Parkinson's disease symptoms are differentially affected by massage therapy vs. progressive muscle relaxation: a pilot study (2002) (51)
- Influence of female sex hormones on neuroleptic-induced behavioral supersensitivity (1980) (45)
- Parkinson's Disease and Nonpharmacologic Treatment Programs (1989) (45)
- Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): [RETIRED] (2006) (44)
- Motor fluctuations in Parkinson's disease. (2006) (43)
- Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. (1988) (43)
- Elderly inpatients (1984) (43)
- Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): [RETIRED] (2006) (41)
- Akinetic‐rigid syndrome in a 13‐year‐old girl with HIV‐related progressive multifocal leukoencephalopathy (1993) (41)
- Meige syndrome (blepharospasm‐oromandibular dystonia) after long‐term neuroleptic therapy (1981) (41)
- Hemichorea‐hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis (1989) (40)
- Pramipexole in progressive supranuclear palsy (1999) (40)
- KICK AND RUSH: PARADOXICAL KINESIA IN PARKINSON DISEASE (2009) (40)
- The comprehensive management of Parkinson's disease (1994) (38)
- Obsessive-compulsive symptoms and motor asymmetries in Parkinson’s disease (1993) (38)
- Opsoclonic cerebellopathy: A paraneoplastic syndrome responsive to thiamine. (1981) (37)
- The pharmacological evaluation of pergolide mesylate as a potential anti-Parkinson agent (1980) (37)
- Movement disorders emergencies Part 2: hyperkinetic disorders. (2011) (36)
- Synucleinopathies from bench to bedside. (2012) (35)
- Early combination therapy with bromocriptine and levodopa in parkinson's disease (1993) (34)
- Methylphenidate‐induced chorea (1978) (34)
- Amphetamine‐induced hypersensitivity in guinea pigs (1979) (34)
- Sexual Dysfunction in Men with Parkinson's Disease (1989) (34)
- Sexual function in patients with Parkinson's disease. (1991) (33)
- A case of post‐traumatic tic disorder (1989) (33)
- Tourette-like symptoms following chronic neuroleptic therapy. (1982) (33)
- Reversal of parkinsonism following liver transplantation (2003) (32)
- Practice Parameter: Neuroprotect n ive Strategies and Alternative Therapies for Parkinso Disease (An Evidence-Based Review) (2006) (32)
- Tardive Dyskinesia: Pharmacology and Clinical Implications (1982) (32)
- Effect of chlorphromazine on central nervous system concentrations of manganese, iron, and copper. (1977) (30)
- Camptocormia in a patient with multiple system atrophy (2005) (29)
- Vitamin E therapy in Parkinson's disease. (1990) (29)
- Delayed‐onset dystonia associated with corticospinal tract dysfunction (1988) (29)
- Bromocriptine‐induced behavioral hypersensitivity (1978) (29)
- Phenvtoin‐induced focal chorea (1996) (29)
- Cocaine and tourette's syndrome (1988) (29)
- Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. (1982) (28)
- Adrenal medullary autografts in patients with Parkinson's disease. (1989) (28)
- The long-term safety and efficacy of pramipexole in advanced Parkinson's disease. (2001) (28)
- Paraquat and Parkinson's disease (1987) (28)
- Cocaine-induced persistent dyskinesias (2001) (28)
- Progress in Parkinson's disease research--2 (1992) (28)
- HIV encephalitis presenting with severe generalized chorea (1996) (27)
- Complications of chronic levodopa therapy (1981) (26)
- Quetiapine for l-dopa–induced psychosis in PD (2000) (25)
- Risperidone in Gilles de la Tourette syndrome (1995) (25)
- Initial treatment of Parkinson disease: levodopa or dopamine agonists. (2004) (25)
- Persistent akathisia following neuroleptic withdrawal (1983) (25)
- Textbook of clinical neuropharmacology (1981) (24)
- Lingual‐Facial‐Buccal Movements in the Elderly. I. Pathophysiology and Treatment (1973) (24)
- Parkinson's Disease: A Complete Guide for Patients and Families (2001) (24)
- What is it? case 1, 1996: Rapidly progressive parkinsonism, incontinence, impotency, and levodopa‐induced moaning in a patient with multiple myeloma (1996) (23)
- Choreoathetosis after surgery for congenital heart disease. (1994) (23)
- Progression of dystonia in complex regional pain syndrome (2005) (22)
- Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cyst (1998) (22)
- Dopaminergic antagonism of L‐5‐hydroxytryptophan‐induced myoclonic jumping behavior (1979) (22)
- Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig. (1981) (22)
- Parkinson's disease. Diagnosis and the initiation of therapy. (2005) (22)
- Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease. (1982) (22)
- Paraquat and Parkinson's disease (1987) (21)
- Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. (1993) (21)
- Levodopa, melanoma, and Parkinson's disease (1993) (21)
- Movement disorders emergencies. Part 1: Hypokinetic disorders. (2011) (21)
- Reduction of serum prostacyclin stability in ischemic stroke. (1985) (20)
- Hyperkinetic movement disorders (2011) (20)
- Dopamine receptor site sensitivity in hyperthyroid guinea pigs: A possible model of hyperthyroid chorea (2005) (20)
- Neurology for the Non-Neurologist (1981) (20)
- Pemoline‐induced chorea (1981) (19)
- What is it?. Case 1, 1995: Psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction (1995) (19)
- Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's disease (1973) (19)
- Drug-Induced Movement Disorders (1992) (18)
- Mania‐induced remission of tardive dyskinesia in manic‐depressive illness (1982) (18)
- Neuroleptic‐Induced Tardive Dyskinesia Variants (2008) (18)
- Could Parkinson's disease follow intra-uterine influenza? A speculative hypothesis. (1989) (18)
- Phenytoin and choreic movements. (1978) (18)
- Observations on the use of methysergide in Huntington's chorea (1972) (17)
- Improvement of both tardive dystonia and akathisia after botulinum toxin injection. (1996) (17)
- Comparison of caregiver strain in Parkinson's disease between Yamagata, Japan, and Maryland, The United States. (2013) (17)
- Progression of Parkinson's disease (1989) (17)
- UPPER LIMB TREMOR INDUCED BY PERIPHERAL NERVE INJURY (2007) (16)
- 21‐Aminosteroids Interact with the Dopamine Transporter to Protect Against 1‐Methyl‐4‐Phenylpyridinium‐Induced Neurotoxicity (1992) (16)
- Lingual‐Facial‐Buccal Movements in the Elderly. II. Pathogenesis and Relationship to Senile Chorea (1973) (16)
- Survey of training programs’ means for promoting neurology and attracting trainees (2006) (16)
- Lergotrile in the treatment of parkinsonism (1978) (16)
- Drug-induced movement disorders: emergencies and management. (2012) (16)
- Psychogenic camptocormia (2007) (16)
- Transient movement disorders and multiple sclerosis. (2002) (16)
- Modafinil for the treatment of excessive daytime sleepiness in Parkinson's disease: a case report. (2001) (15)
- Amantadine-induced peripheral neuropathy. (1999) (15)
- Sexual Dysfunction: A Neuro-Medical Approach (1994) (15)
- Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): [RETIRED] (2006) (15)
- Levodopa—toxic or neuroprotective? (2006) (15)
- Early diagnosis of Parkinson's disease and initiation of treatment. (2008) (14)
- Progress in Parkinson Research (1989) (14)
- The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper (1978) (14)
- Late presentation of congenital muscular torticollis: Use of MR imaging and CT scan in diagnosis (1994) (14)
- Progressive supranuclear palsy. (2007) (13)
- Metformin-associated mortality in U.S. studies. (1996) (13)
- Is levodopa toxic? (2000) (13)
- Arsenic intoxication in a cocaine abuser. (1989) (13)
- The Current Clinical Picture Of Parkinson’S Disease (1988) (13)
- To the Editor (1995) (13)
- CHOLINERGIC-MONOAMINERGIC INTERACTIONS WITHIN THE STRIATUM: IMPLICATIONS FOR CHOREIFORM DISORDERS (1978) (13)
- 5-Hydroxytryptophan induced behavior in intact guinea pigs. (1973) (13)
- What do clinical trials tell us about treating patients? (2009) (13)
- Clonazepam and dopamine-related stereotyped behavior. (1977) (12)
- Neuropsychological Correlates of Early Parkinson's Disease: Evidence for Frontal Lobe Dysfunction (1988) (12)
- Successful treatment of hemichorea with olanzapine (1999) (12)
- Dementia in Parkinson's disease. (2009) (12)
- A retrospective analysis of the effects of anticholinergic medication on memory performance in Parkinson's disease. (1991) (12)
- Adolf Kussmaul and His Respiratory Sign (2001) (11)
- Post-traumatic movement disorders. (1995) (11)
- Metatarsal fracture as a consequence of foot dystonia in Parkinson's disease. (2008) (11)
- Chapter 8: Pharmacology of Ballismus (1979) (11)
- "Trick" movements in facial dystonia. (1984) (11)
- Regional Brain Manganese Levels in an Animal Model of Tardive Dyskinesia (1980) (10)
- Does spouse participation influence quality of life reporting in patients with Parkinson’s disease? (2014) (10)
- Amantadine-induced peripheral neuropathy (1999) (10)
- A differential diagnosis of Parkinsonism. (2005) (10)
- Metoclopramide-Induced Encephalopathy in Parkinson Disease (2010) (10)
- Levodopa-induced dopaminergic hypersensitivity in the pathogenesis of psychiatric and neurologic disorders. (1979) (10)
- Acetaminophen metabolism by cytochrome P450 monooxygenases in Parkinson's disease (1989) (10)
- Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease. (1989) (10)
- Levodopa-free periods ("drug holidays") in the management of parkinsonism. (1983) (10)
- Clinical and experimental studies of phenytoin-induced hyperkinesias (2005) (10)
- The effects of gait impairment with and without freezing of gait in Parkinson's disease. (2012) (10)
- Dopamine receptor site sensitivity in hyperthyroid and hypothyroid guinea pigs. (1974) (10)
- Chorea gravidarum. (2011) (9)
- Clonazepam and 5-hydroxytryptophan-induced myoclonic stereotypy. (1977) (9)
- Do parkinsonians exhibit visuospatial deficits? (1990) (9)
- Acquired abducens-trigeminal synkinesis (1998) (9)
- Emergent and urgent neurology (1992) (9)
- Clinical Reasoning: A 44-year-old man with a 3-month history of hiccups (2011) (9)
- Perdiem causing esophageal obstruction in Parkinson’s disease (1999) (9)
- Chapter 1: Prevention and Management of the Side Effects of Levodopa (1977) (8)
- Practical guidelines for drug holidays in parkinsonian patients (1981) (8)
- Agonist or levodopa for Parkinson disease? (2008) (8)
- Iron storage and transport markers in Parkinson’s disease and MPTP-treated mice (1993) (8)
- The effect of dimethylaminoethanol (deanol) on amphetamine-induced stereotyped behavior (AISB). (1976) (8)
- Validation of the ANAM Test Battery in Parkinson's Disease (2005) (8)
- Defining features, clinical conditions, and theoretical constructs of stereotyped movements. (1996) (8)
- The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity (1977) (8)
- Respiratory dysfunction in neurologic disease (1980) (7)
- The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's disease. (1989) (7)
- 1.3.1 SYNUCLEINOPATHIES FROM BENCH TO BEDSIDE (PD, MSA, ADHD, RLS) (2012) (7)
- Bromocriptine: decreased clinical effects at higher dosages. (1979) (6)
- Levodopa-responsive parkinsonism in a patient with Down's syndrome. (1990) (6)
- Transderm-induced psychosis in Parkinson’s disease (1999) (6)
- When do patients with Parkinson disease disclose their diagnosis? (2006) (6)
- Retrospective Evaluation of Vitamin E Therapy in Parkinson's Disease (1989) (6)
- Adaptive Changes in Central Dopaminergic Neurons after Injury (1988) (6)
- Primary Dystonias (1995) (6)
- Are Patients with Psychogenic Movement Disorders More Likely to be Healthcare Workers? (2017) (5)
- Pearls and Oy-sters: The utility of cytology and flow cytometry in the diagnosis of leptomeningeal leukemia (2013) (5)
- Psychosis in Parkinson's disease: case studies. (2006) (5)
- THE DAILY FLUCTUATION OF STRIATAL DOPAMINE CONTENT AND d-AMPHETAMINE AND APOMORPHINE INDUCED STEREOTYPIC BEHAVIOR (1979) (5)
- Carbidopa-levodopa ratio in Parkinson's disease. (1981) (5)
- Comparison of Quality of Life and Disability in Three Different Dementias (P07.180) (2012) (5)
- The neurology and corresponding genetics of fragile X disorders: insights into the genetics of neurodegeneration (2013) (5)
- Chapter 5: Vitamin B6 in the Pathogenesis and Treatment of Diseases of the Central Nervous System (1976) (4)
- Psychiatric symptoms in Parkinson’s disease (2002) (4)
- Pallidotomy in advanced Parkinson's disease. (1998) (4)
- Movement Disorders Emergencies Part 2 (2011) (4)
- Correlation between daily dosage of chlorpromazine and subsequent supersensitivity. (1980) (4)
- Movement Disorders and Dopaminomimetic Stimulant Drugs (2008) (4)
- Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness. (1997) (4)
- A double‐blind evaluation of ciladopa in Parkinson's disease (1987) (3)
- Early‐stage Parkinson's disease: To treat or not to treat (1994) (3)
- Recent advances in the biochemical pharmacology of extrapyramidal movement disorders. (1977) (3)
- Multiple system atrophy. (2010) (3)
- Biochemical and Behavioral Studies of Neuroleptic-lnduced Dopamine Hypersensitivity (1980) (3)
- J. Clifford Richardson and 50 years of progressive supranuclear palsy (2009) (3)
- Reply from the Authors (1996) (3)
- Teaching NeuroImages: Rest tremor mimicking ventricular tachycardia (2010) (3)
- Psychogenic tremors. (1989) (3)
- Advances in the diagnosis, treatment, and understanding of Parkinson's disease and parkinsonism. (2006) (3)
- DIAGNOSTIC TESTING FOR DEMENTIA IN PATIENTS WITH PARKINSON'S DISEASE (1996) (3)
- Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice. (1993) (3)
- Initiating therapy in Parkinson's disease (2009) (2)
- Effect of pergolide mesylate, an ergoline, in animal models of Parkinson's disease: implications for therapy. (1979) (2)
- Effect of ciladopa on Parkinson's disease: a preliminary report. (1987) (2)
- Anticholinergics and tardive dyskinesia. (1980) (2)
- Levodopa‐induced dyskinesias in normal squirrel monkeys (2002) (2)
- American Academy of Neurology evidence-based review): Report of the Quality Standards Subcommittee of the Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an (2007) (2)
- Worth of neurologists (1996) (2)
- Abrupt versus gradual withdrawal of antiparkinsonians. (1982) (2)
- THE TIME COURSE OF HALOPERIDOL-INDUCED DOPAMINE RECEPTOR SITE SUPERSENSITIVITY IN GUINEA PIGS (1979) (2)
- What is it? Case 2, 1994: Parkinsonism and cognitive impairment (1994) (2)
- Practice patterns of US neurologists in patients with SPMS and PPMS: A consensus study. (2012) (2)
- Meige??s syndrome during long-term dopaminergic therapy in Parkinson??s disease (1982) (2)
- Group visits for Parkinson disease (2011) (2)
- Standards Subcommittee of the American Academy of Neurology Practice Parameter: Therapies for essential tremor: Report of the Quality (2009) (2)
- Cognition in Parkinson's disease (1989) (2)
- Flexible residency program (2010) (1)
- Complications of chronic levodopa therapy (1981) (1)
- James Parkinson: The Man and the Essay (2002) (1)
- Drug-Induced Tics (2004) (1)
- Temporary levodopa withdrawal. (1986) (1)
- Huntington's Disease: Current Concepts of Therapy * (1979) (1)
- Diagnosis and prognosis of new-onset Parkinson's disease (2006) (1)
- Letters to the editor (1993) (1)
- Re: Clinical significance of ultrastructural findings in the corpora cavernosa of normal and impotent men. (1991) (1)
- Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease (2010) (1)
- Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole. (2000) (1)
- THE ROLE OF SCHEDULING IN AMPHETAMINE HYPERSENSITIVITY AND TOLERANCE (1979) (1)
- Computer skills in patients with movement disorders. (2005) (1)
- 2.15.1 PSYCHOGENIC MOVEMENT DISORDERS (1) (2012) (1)
- Paroxysmal movement disorders. (1995) (1)
- Your Questions Answered: PARKINSONʼS DISEASE (2007) (1)
- Electromyography during Stereotactic Pallidotomy for Parkinson’s Disease (2000) (1)
- Conflicts of interest in expert witnesses (2006) (1)
- Effects of caudate-capsular stimulation on thalamic ventrolateral unitary activity in the cat. (1967) (1)
- Hyperkinetic movement disorders. Preface. (2011) (1)
- Chapter 11: Pharmacology of Minimal Brain Dysfunction (1978) (1)
- Drug holiday and management of Parkinson disease (1982) (1)
- Handbook of Dystonia (1996) (1)
- Amantadine in Huntington's chorea. (1972) (1)
- A Tale of Two Tauopathies (2011) (1)
- Parkinsonism: is your treatment appropriate? (1980) (1)
- The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. (1981) (1)
- NIEMANN-PICK ; TYPE C. AUTHORS' REPLY (1996) (1)
- Driving and the Elderly (2002) (0)
- Modified out patient drug holiday in the management of parkinsonism (1981) (0)
- Male sexual dysfunction (1996) (0)
- Explorer Criteria for the diagnosis of corticobasal degeneration (2015) (0)
- Comprar Hyperkinetic Movement Disorders Handbook of Clinical Neurology Vol. 100 (Series Editors: Aminoff, Boller and Swaab) | William J. Weiner, MD | 9780444520142 | Elsevier Internacional (2011) (0)
- Drug holidays in management of Parkinson disease (1982) (0)
- Muscle stiffness and muscle pain. (1981) (0)
- Does Spouse Participation Influence Quality of Life Reporting in Patients with Parkinson's Disease? (P06.063) (2012) (0)
- Appendix C: Practice parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidenced-based review): Report of the Quality Standards Subcommitte of the American Academy of Neurology (2007) (0)
- To the Editor (1991) (0)
- Book Reviews (2005) (0)
- Analysis of the Protective Effects of 21‐Aminosteroids in MPP+‐Induced Neurotoxicity to Dopaminergic Neurons in Mesencephalic Cultures a (1992) (0)
- What Level of Parkinson’s Disease Severity Is Associated with Significant Differences in Cognitive Function? (P5.258) (2014) (0)
- Bromocriptine and dopamine receptor hypersensitivity (1979) (0)
- Combination therapy for PD (1993) (0)
- Placebo surgery in trials of therapy for Parkinson's disease. (2000) (0)
- Third Annual Huntington Disease Clinical Research Symposium (2011) (0)
- Poster 12: Self-Efficacy in Health Behaviors: Is There a Difference in Huntington vs Parkinson Disease? (2010) (0)
- Common movement disorders (1992) (0)
- Gait dysfunction and cognition. (2010) (0)
- Ropinirole as compared with levodopa in Parkinson's disease. (2000) (0)
- Author's reply (2000) (0)
- The effect of bromocriptine (BCT) on the on-off phenomenon (2005) (0)
- available empirical evidence and give specific recommendations for the identification of children with autism Target Population Infants and children Interventions and Practices Considered Developmental Surveillance and Screening : 1 . Developmental surveillance at all well-child visits from infancy (0)
- Practice patterns of US neurologists in patients with SPMS and PPMS: A consensus study. (2012) (0)
- Comparison of Disability and Quality of Life in Parkinsonian Syndromes (P06.067) (2012) (0)
- DIAGNOSIS AND TREATMENT UPDATE Essential Tremor (2010) (0)
- Multiple Sclerosis Functional Composite vs. UPDRS: Which Is the More Sensitive Measure in PD? (P04.188) (2013) (0)
- The Effect of Lithium on Haloperidol-lnduced Supersensitivity to D-Amphetamine and Apomorphine (1980) (0)
- Symptoms and Signs Help Differentiate Parkinsonism from Parkinson Disease (2005) (0)
- Appendix H: Practice Parameter: Therapies for essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology (2007) (0)
- 232 IS GAIT INSTABILITY AND INTELLECTUAL IMPAIRMENT RARE IN EARLY CORTICOBASAL DEGENERATION (2010) (0)
- Third Annual Huntington Disease Clinical Research Symposium : Organized by the Huntington Study Group (Huntington Study Group Abstracts) (2010) (0)
- Research update on Parkinson's disease and other movement disorders: highlights from the Eighteenth Annual Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders, October 3, 2004, Toronto, Ontario, Canada. (2005) (0)
- Appendix D: Practice parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidenced-based review): Report of the Quality Standards Subcommitte of the American Academy of Neurology (2007) (0)
- COMBINATION THERAPY FOR PD. AUTHOR'S REPLY (1993) (0)
- 27. Sexual Dysfunction (2011) (0)
- Movement Disorder: Medical Perspective (2008) (0)
- "Catecholamines" in the brain. (1970) (0)
- Ongoing clinical trials for Parkinson's disease (2006) (0)
- P2.050 Do pre-existing psychiatric disorders affect quality of life following deep brain stimulation for Parkinson's disease? (2009) (0)
- Initiating Therapy in Parkinson's Disease. Authors' reply (2009) (0)
- Parkinson's disease and related syndromes. (1993) (0)
- Discordance between Physician Assessment and Patient-Reported Depressive Symptoms in Parkinson's Disease (S03.002) (2013) (0)
- 145 THE RELATIONSHIP BETWEEN GAIT IMPAIRMENT AND SELF-EFFICACY IN PARKINSON'S DISEASE (2010) (0)
- Reply by Authors. (2020) (0)
- Evidence for the Existence of Two Striatal Dopamine Receptors (1979) (0)
- Biochemical diagnosis of neurodegenerative diseases gets closer (2011) (0)
- Parkinsonism and Parkinson's disease. (1996) (0)
- Bromocriptine (1979) (0)
- P2.048 The impact of gait and mental function on disability in Parkinson's disease (2008) (0)
- NATURE OF DOPAMINE RECEPTORS IN THE STRIATUM AND NUCLEUS ACCUMBENS (1979) (0)
- 2628 – THE DEVELOPMENT OF 3H-DOPAMINE BINDING SITES IN GUINEA PIG STRIATAL MEMBRANES (1978) (0)
- P1.127 Parkinson's disease subtypes and their relevance to studies of disease-modifying agents (2009) (0)
- Levodopa or dopamine agonists in the early treatment of Parkinson's disease (2000) (0)
- Twelfth annual symposia on etiology, pathogenesis, and treatment of parkinson's disease and etiology, pathogenesis, and treatment of Huntington's disease (1998) (0)
- 2549 – THE ROLE OF DOPAMINERGIC MECHANISMS IN NALOXONE INDUCED INHIBITION OF APOMORPHINE STEREOTYPY (1978) (0)
- CME Practice Parameter : Neuroprotective strategies and alternative therapies for Parkinson disease ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology (2006) (0)
- Medical and surgical treatments for Parkinson's disease (2006) (0)
- Is Quality of Life Affected Equally by Decline and Improvement in Parkinson Disease Severity? (P06.062) (2012) (0)
- Chorea induced by oral contraceptives (1980) (0)
- A New Anti-PD Drug? (2007) (0)
- Poster 10: Degree of Disability Is Predictive of Physical But Not Mental Health Quality of Life in Huntington's Disease (2010) (0)
- Book Review (2010) (0)
- Comprar Neurology for the Non-Neurologist 6ed | Christopher G. Goetz | 9781605472393 | Lippincott Williams & Wilkins (2010) (0)
- Levodopa Improves Psychiatric Symptoms of Parkinson's Disease More Than Dopamine Agonists (P04.195) (2013) (0)
- Do we need more drugs to treat Parkinson's disease? (1999) (0)
- Platform presentation—Early vs Late Huntington's Disease: Is There a Difference in Psychiatric Symptom Severity? (2010) (0)
- Letter to the editor (0)
- O.075 Atypical parkinsonism (2009) (0)
- Movement disorders. (2018) (0)
- Another trial, another hour (2011) (0)
- Imaging Acute NeurologicDisease: Non-Parkinson’s disease tremor (2014) (0)
- Hyperkinetic Movement Disorders Handbook of Clinical Neurology Vol. 100 (Series Editors: Aminoff, Boller and Swaab) (2011) (0)
- Parkinson's disease: an enigma: highlights from the 8th International Congress of Parkinson's Disease and Movement Disorders, June 13-17, 2004, Rome, Italy. (2005) (0)
- Parkinsonian features and progressive supranuclear palsy. (1982) (0)
- Essential tremor. (2010) (0)
- POST-TRAUMATIC MOVEMENT DISORDERS. AUTHOR'S REPLY (1995) (0)
- WHAT CAUSED VISUAL LOSS IN A PREGNANT WOMAN (2006) (0)
- Are Patients with Psychogenic Movement Disorders More Likely To Be Healthcare Workers? (P04.033) (2012) (0)
- Early-onset primary dystonia. (2011) (0)
- Letters to the editor (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William J. Weiner?
William J. Weiner is affiliated with the following schools:
